BVXV logo

BiondVax Pharmaceuticals (BVXV) Net Income

Annual Net Income

-$5.80 M
+$2.41 M+29.37%

December 31, 2022

Summary

Performance

1-Year Change

+29.37%

3-Year Change

+81.62%

5-Year Change

+41.7%

15-Year Change

+41.7%

BVXV Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.39 M

3-Year Low

-$8.21 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BVXV previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BVXV next annual earnings announcement has not yet been scheduled

OtherBVXVprofitabilitymetrics:

Annual Net Margin

-
BVXV annual net profit margin value is unknown

Annual Revenue

-
BVXV annual revenue value is unknown

Annual Gross Profit

-
BVXV annual gross profit value is unknown

Annual EPS

-$4.00
BVXV annual earnings per share is -$4.00

Quarterly Net Income

-$3.76 M
-$247.00 K-7.03%

June 30, 2023

Summary

Performance

3-Month Change

-7.03%

1-Year Change

-26.11%

3-Year Change

+69.11%

5-Year Change

+46.01%

BVXV Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$16.04 M
BVXV quarterly net profit is currently -123.45% below its historical high of $16.04 million

3-Year Low

-$3.76 M
BVXV quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BVXV previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BVXV next earnings announcement has not yet been scheduled

OtherBVXVprofitabilitymetrics:

Quarterly Net Margin

-
BVXV quarterly net profit margin value is unknown

Quarterly Revenue

-
BVXV quarterly revenue value is unknown

Quarterly Gross Profit

-
BVXV quarterly gross profit value is unknown

Quarterly EPS

-$1.20
BVXV quarterly earnings per share is -$1.20

TTM Net Income

-$6.83 M
-$779.00 K-12.88%

June 30, 2023

Summary

Performance

3-Month Change

-12.88%

1-Year Change

+7.73%

3-Year Change

+78.2%

5-Year Change

+78.12%

BVXV TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.72 M
BVXV TTM net profit is currently -219.23% below its historical high of $5.72 million

3-Year Low

-$8.10 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BVXV previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BVXV next earnings announcement has not yet been scheduled

OtherBVXVprofitabilitymetrics:

Annual Net Margin

-
BVXV annual net profit margin value is unknown

TTM Revenue

-
BVXV TTM revenue value is unknown

TTM Gross Profit

-
BVXV TTM gross profit value is unknown

TTM EPS

-$3.03
BVXV TTM earnings per share is -$3.03

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$5.80 M
BVXV annual net profit is -$5.80 million

Annual Revenue

-
BVXV annual revenue value is unknown

Annual Cost Of Goods Sold

-
BVXV annual cost of goods sold value is unknown

Annual Operating Expenses

$11.06 M
BVXV annual total operating expenses is $11.06 million

Annual Interest Expense

-
BVXV annual interest expense value is unknown

Annual Income Tax

-
BVXV annual income tax value is unknown

BVXV Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.4%-26.1%+7.7%
3 y3 years+81.6%+69.1%+78.2%
5 y5 years+41.7%+46.0%+78.1%

BVXV Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+41.6%-457.8%at low+93.0%+18.6%
5 y5-year+318.3%+444.1%-123.5%+233.2%-219.2%+374.5%
alltimeall time+318.3%+444.1%-123.5%+252.5%-219.2%+374.5%

BiondVax Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Jun 2023
-
-$3.76 M(+7.0%)
-$6.83 M(+12.9%)
Mar 2023
-
-$3.52 M(+486.2%)
-$6.05 M(+20.8%)
Dec 2022
-$5.80 M(-29.4%)
-$599.60 K(-157.0%)
-$5.01 M(+41.5%)
Sep 2022
-
$1.05 M(-135.2%)
-$3.54 M(-52.2%)
Jun 2022
-
-$2.98 M(+20.5%)
-$7.40 M(-8.7%)
Mar 2022
-
-$2.48 M(-384.5%)
-$8.10 M(+0.3%)
Dec 2021
-$8.21 M(+492.3%)
$869.90 K(-131.0%)
-$8.07 M(-38.5%)
Sep 2021
-
-$2.81 M(-23.7%)
-$13.13 M(-329.3%)
Jun 2021
-
-$3.68 M(+50.3%)
$5.72 M(-306.7%)
Mar 2021
-
-$2.45 M(-41.4%)
-$2.77 M(+104.7%)
Dec 2020
-$1.39 M(-95.6%)
-$4.18 M(-126.1%)
-$1.35 M(-86.1%)
Sep 2020
-
$16.04 M(-231.7%)
-$9.71 M(-69.0%)
Jun 2020
-
-$12.18 M(+1076.6%)
-$31.30 M(-3.3%)
Mar 2020
-
-$1.03 M(-91.7%)
-$32.39 M(+3.8%)
Dec 2019
-$31.53 M(+35.4%)
-$12.54 M(+125.6%)
-$31.20 M(+2.8%)
Sep 2019
-
-$5.56 M(-58.1%)
-$30.34 M(+19.4%)
Jun 2019
-
-$13.26 M(-8599.9%)
-$25.41 M(+32.9%)
Mar 2019
-
$156.00 K(-101.3%)
-$19.12 M(-18.0%)
Dec 2018
-$23.29 M
-$11.68 M(+1775.9%)
-$23.32 M(+52.5%)
Sep 2018
-
-$622.80 K(-91.1%)
-$15.29 M(+6.9%)
Jun 2018
-
-$6.97 M(+72.3%)
-$14.29 M(+33.9%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$4.04 M(+10.8%)
-$10.67 M(+7.9%)
Dec 2017
-$9.94 M(+316.4%)
-$3.65 M(-1088.9%)
-$9.89 M(+44.8%)
Sep 2017
-
$369.20 K(-111.0%)
-$6.83 M(-12.7%)
Jun 2017
-
-$3.35 M(+2.5%)
-$7.83 M(+51.7%)
Mar 2017
-
-$3.27 M(+453.0%)
-$5.16 M(+118.2%)
Dec 2016
-$2.39 M(-8.6%)
-$590.50 K(-5.9%)
-$2.37 M(-9.8%)
Sep 2016
-
-$627.50 K(-7.5%)
-$2.62 M(+33.7%)
Jun 2016
-
-$678.20 K(+44.4%)
-$1.96 M(-26.2%)
Mar 2016
-
-$469.80 K(-44.6%)
-$2.66 M(-0.0%)
Dec 2015
-$2.61 M(+31.0%)
-$848.40 K(-2588.0%)
-$2.66 M(+22.0%)
Sep 2015
-
$34.10 K(-102.5%)
-$2.18 M(-19.3%)
Jun 2015
-
-$1.38 M(+192.1%)
-$2.70 M(+36.9%)
Mar 2015
-
-$471.10 K(+27.8%)
-$1.98 M(-4.4%)
Dec 2014
-$1.99 M(-13.6%)
-$368.60 K(-24.5%)
-$2.07 M(-12.5%)
Sep 2014
-
-$488.40 K(-24.6%)
-$2.36 M(-2.4%)
Jun 2014
-
-$647.60 K(+15.3%)
-$2.42 M(+36.5%)
Mar 2014
-
-$561.70 K(-15.3%)
-$1.77 M(+46.4%)
Dec 2013
-$2.31 M(-7.6%)
-$663.20 K(+21.2%)
-$1.21 M(+121.2%)
Sep 2013
-
-$547.10 K
-$547.10 K
Dec 2012
-$2.50 M(+23.2%)
-
-
Dec 2011
-$2.03 M
-
-

FAQ

  • What is BiondVax Pharmaceuticals annual net profit?
  • What is the all time high annual net income for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals annual net income year-on-year change?
  • What is BiondVax Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals quarterly net income year-on-year change?
  • What is BiondVax Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for BiondVax Pharmaceuticals?
  • What is BiondVax Pharmaceuticals TTM net income year-on-year change?

What is BiondVax Pharmaceuticals annual net profit?

The current annual net income of BVXV is -$5.80 M

What is the all time high annual net income for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high annual net profit is -$1.39 M

What is BiondVax Pharmaceuticals annual net income year-on-year change?

Over the past year, BVXV annual net profit has changed by +$2.41 M (+29.37%)

What is BiondVax Pharmaceuticals quarterly net profit?

The current quarterly net income of BVXV is -$3.76 M

What is the all time high quarterly net income for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high quarterly net profit is $16.04 M

What is BiondVax Pharmaceuticals quarterly net income year-on-year change?

Over the past year, BVXV quarterly net profit has changed by -$779.00 K (-26.11%)

What is BiondVax Pharmaceuticals TTM net profit?

The current TTM net income of BVXV is -$6.83 M

What is the all time high TTM net income for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high TTM net profit is $5.72 M

What is BiondVax Pharmaceuticals TTM net income year-on-year change?

Over the past year, BVXV TTM net profit has changed by +$572.10 K (+7.73%)